Quantum Cyber N.V.
- Last sale
- Nov 12, 2026 · -9.28%
- Market cap
- $49.21M
- 87.24M shares
- Filings
- 207
Q3 2026−39.9% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derivedN/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026−85.7% FY25 yoy
- $49.21M
- —
- 91.6×
- 3.0×
- -22.31%
- —
FY2025 figures · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $537,080 | reported | |
| FY 2024 | 2024-12-31 | $893,991 | reported | |
| FY 2023 | 2023-12-31 | $895,479 | reported | |
| FY 2022 | 2022-12-31 | $529,877 | reported | |
| FY 2021 | 2021-12-31 | $577,348 | reported | |
| FY 2020 | 2020-12-31 | $493,565 | reported | |
| FY 2019 | 2019-12-31 | $281,393 | reported |
Segments
LineFY2025ShareChange
Genetic Diagnostic$4.63M87%—
Corporate$701.60K13%—
Total$5.33M
Pharmaceutical preparations
Quantum Cyber N.V. is the 227th largest of the 552 covered companies the SEC files under this code, by revenue. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
PMHSPolomar Health Services, Inc.$648.2K1,002.0%1,650.8%$3.7MBTAIQBioXcel Therapeutics, Inc.$642.0K71.7%10,887.4%$313.1KELABPMGC Holdings Inc.$590.1K—1,313.0%$1.9MYARWYarrow Bioscience, Inc.$570.0K13.8%4,646.1%$296.8MSLNSilence Therapeutics plc$559.0K98.7%15,851.9%$3.7B
QUCYQuantum Cyber N.V. (this company)$537.1K39.9%3,018.3%$49.2M
MREOMereo BioPharma Group plc$500.0K—8,375.6%$243.3MSCNXScienture Holdings, Inc.$431.6K215.9%9,618.0%$5.2MMNOVMedicinova Inc$409.7K—2,928.8%$72.0MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Quantum Cyber N.V. · CIK 1874252 · Engraved from SEC EDGAR